The CAF20 antibody is a specialized immunological reagent designed to detect and study Caf20p, a conserved eukaryotic translation initiation factor-binding protein in Saccharomyces cerevisiae. Caf20p functions as a 4E-BP (eIF4E-binding protein) that regulates mRNA translation by competing with eIF4G for binding to eIF4E, a key component of the mRNA 5' cap recognition complex . This antibody enables researchers to investigate Caf20p's dual roles in translation repression and ribosome association, as well as its phosphorylation dynamics under nutrient stress .
CAF20 antibodies have been generated using multiple strategies:
Epitope-tagged variants: FLAG-tagged Caf20 mutants (e.g., Caf20-FLAG) allow detection via commercial anti-FLAG antibodies, validated in immunoprecipitation (IP) and Western blotting .
Polyclonal antisera: Rat polyclonal antibodies raised against recombinant Caf20 protein enable native protein detection in co-IP experiments .
Specificity confirmed by absence of cross-reactivity with other 4E-BPs like Eap1 .
Robust detection in ribosome fractionation assays, showing Caf20p's distribution across polysome and 80S ribosomal fractions .
| Mutant | eIF4E Binding | Ribosome Association | Source |
|---|---|---|---|
| Wild-type (WT) | Yes | Yes | |
| ∆1 (N-terminal deletion) | No | Reduced | |
| ∆5-∆8 (C-terminal deletions) | Yes | 50% reduction | |
| m2 (eIF4E-binding motif mutant) | No | Yes |
Caf20p binds ribosomes independently of eIF4E via dispersed regions, including residues 48–108 .
Co-immunoprecipitation with eIF4E requires an intact N-terminal helix (residues 1–20) .
CAF20 antibodies identified phosphorylation events under nutrient stress:
In vitro kinase assays: TORC1 phosphorylates Caf20p, with activity inhibited by tRNA .
Ribosome profiling: Phosphorylated Caf20p accumulates in 80S ribosomal fractions during rapamycin treatment .
CAF20 antibodies have been critical for:
Co-immunoprecipitation (co-IP):
Chemical crosslinking:
Polysome profiling:
Dual mRNA targeting: Caf20p interacts with 500+ mRNAs, 75% via eIF4E-dependent mechanisms and 25% via 3' UTR motifs .
Growth regulation: ∆caf20 strains show accelerated growth in rich media, linking translation control to cell proliferation .
Ribosome coupling: Caf20p's ribosome association may facilitate rapid eIF4E binding after scanning complex dissociation .
KEGG: sce:YOR276W
STRING: 4932.YOR276W
CAF20 (also known as Caf20p in yeast) is an eIF4E-binding protein (4E-BP) that mediates both eIF4E-dependent and independent translation regulation. It interacts with a core set of over 500 mRNAs, comprising both eIF4E-dependent (75%) and eIF4E-independent targets (25%) . These mRNAs are primarily involved in transcription and cell cycle processes, consistent with observed cell cycle phenotypes in mutant strains. CAF20 functions as a translational repressor by competing with eIF4G for binding to eIF4E, thereby preventing the assembly of the translation initiation complex.
The interaction between CAF20 and eIF4E is entirely dependent on the CAF20 amino terminal helix . This interaction involves a canonical 4E-binding motif at the extreme amino terminus of CAF20. Mutations in this region (such as the m2 mutations) completely disrupt binding to eIF4E, while surprisingly, the remaining parts of CAF20 do not appear to significantly impact eIF4E interactions . The canonical amino-terminal helix is therefore both necessary and sufficient for the CAF20-eIF4E interaction.
Yes, CAF20 binds directly or indirectly to ribosomes independently from its interaction with eIF4E . The m2 mutant of CAF20, which cannot bind eIF4E, still associates with ribosomes, confirming that these interactions are separate. Unlike the discrete binding site for eIF4E, there is no single region on CAF20 that mediates ribosome interaction. Instead, multiple regions along CAF20 contribute to ribosome binding . Ribosome association is resistant to RNase I treatment, suggesting that CAF20-mRNA interactions are not essential for 80S ribosome binding.
For effective CAF20 immunoprecipitation, magnetic beads coated with IgG that have reduced non-specific interactions are recommended, combined with a competitive peptide elution step to recover bound proteins . When using tagged versions of CAF20 (such as CAF20-TAP or CAF20-FLAG), it's important to verify that the tag doesn't interfere with protein function. For FLAG-tagged CAF20, anti-FLAG beads can be used for immunoprecipitation .
To distinguish between direct protein-protein interactions and RNA-mediated associations, perform parallel immunoprecipitations with and without RNase I treatment. This approach has revealed that while CAF20 associates with eIF4E directly, its binding to various RNA-binding proteins is RNase-sensitive, indicating RNA-dependent interactions .
To validate a CAF20 antibody, follow these steps:
Use a knockout or knockdown control (caf20Δ strain) alongside wild-type samples to confirm antibody specificity
Perform western blotting with recombinant CAF20 protein as a positive control
Check for cross-reactivity with related proteins (e.g., Eap1p, another yeast 4E-BP)
Validate by immunoprecipitation followed by mass spectrometry to confirm that the antibody pulls down CAF20 and its known interacting partners
Test antibody specificity across different experimental conditions, as protein modifications may affect epitope recognition
Enhanced validation should follow standardized procedures to ensure reproducibility across research applications .
When studying CAF20 phosphorylation:
Include both phosphatase-treated and untreated samples to confirm phosphorylation status
Use TORC1 inhibitors (such as rapamycin) as a negative control, since TORC1 directly phosphorylates CAF20
Employ phospho-specific antibodies if available, or use Phos-tag gels to detect mobility shifts
Include the 4E-BP1 protein as a positive control for TORC1 kinase activity assays
Consider tRNA as an experimental variable, as it suppresses TORC1-mediated phosphorylation of CAF20
It's important to note that TORC1 activity toward CAF20, similar to its activity toward 4E-BP1 and Atg13, is inhibited by tRNA, which should be considered when designing phosphorylation experiments .
To distinguish between eIF4E-dependent and eIF4E-independent functions of CAF20:
Generate CAF20 m2 mutants that specifically disrupt eIF4E binding without affecting other functions
Perform ribosome association assays with both wild-type and m2 mutant CAF20 to identify functions that persist despite loss of eIF4E binding
Conduct RNA immunoprecipitation followed by sequencing (RIP-Seq) to identify both eIF4E-dependent (75%) and eIF4E-independent mRNA targets (25%)
Compare protein expression profiles between wild-type, caf20Δ, and m2 mutant strains using whole-cell proteomics
Analyze sequence attributes of eIF4E-dependent and eIF4E-independent mRNA targets (e.g., eIF4E-independent mRNAs share a 3' UTR motif)
This multi-faceted approach can reveal distinct molecular pathways affected by CAF20 through its eIF4E-dependent and independent mechanisms.
Several complementary techniques can be used to study CAF20's protein interaction network:
Chemical cross-linking coupled with mass spectrometry: Use cross-linkers like bismaleimidohexane (BMH), m-maleimidobenzoyl-N-hydroxysuccinimide ester (MBS), or disuccinimidyl suberate (DSS) to capture CAF20 interactions . Note that CAF20 has a single cysteine at residue 82, which influences cross-linking efficiency with different reagents .
Co-immunoprecipitation with and without RNase treatment: This approach distinguishes direct protein-protein interactions from RNA-mediated associations .
Sucrose cushion fractionation: Separate cell extracts into ribosome-bound and free fractions to evaluate CAF20 association with ribosomes and the impact of mutations on this association .
Label-free LC-MS/MS after TAP purification: This method has identified 116 proteins (FDR<0.05) associated with CAF20, including many RNA-binding proteins .
| Cross-linker | Target groups | Spacer arm length | CAF20-eIF4E cross-linking |
|---|---|---|---|
| BMH | Cys-Cys | 13 Å | No |
| MBS | Lys-Cys | 7.3 Å | Yes |
| DSS | Lys-Lys | 11.4 Å | Yes |
TORC1, a master regulator of cell growth, directly phosphorylates CAF20 . This phosphorylation may regulate CAF20's interaction with eIF4E and its role in translation regulation, similar to how mammalian TORC1 (mTORC1) phosphorylates the eIF4E-binding protein 1 (4E-BP1) to regulate its interaction with eIF4E.
Key findings regarding TORC1 phosphorylation of CAF20 include:
TORC1 directly phosphorylates CAF20 in vitro, along with 4E-BP1
In response to rapamycin (a TORC1 inhibitor) and nitrogen starvation, the 80S monosome exhibits an increase while the polysome fraction decreases
Research on the specific phosphorylation sites on CAF20 and how they affect its binding to eIF4E and ribosomes would provide valuable insights into the regulation of translation under different nutritional conditions.
Non-specific binding of CAF20 antibody in Western blots could be due to several factors:
Cross-reactivity with related proteins: CAF20 is an eIF4E-binding protein with structural similarities to other 4E-BPs like Eap1p in yeast. Ensure the antibody is specific to CAF20 and doesn't cross-react with related proteins.
Insufficient blocking: Optimize blocking conditions by testing different blocking agents (BSA, non-fat milk) and durations.
Degradation products: CAF20 may undergo degradation during sample preparation, resulting in multiple bands. Use fresh samples and add protease inhibitors during cell lysis.
Post-translational modifications: CAF20 is phosphorylated by TORC1 , which could affect antibody recognition and band migration. Consider using phosphatase treatment to verify if multiple bands are due to phosphorylation.
Antibody concentration: Too high antibody concentration can increase background signals. Titrate the antibody to find the optimal concentration.
Always include appropriate controls, such as samples from a caf20Δ strain, to identify specific bands .
Several factors can influence CAF20 immunoprecipitation efficiency:
Cell lysis conditions: Harsh lysis conditions may disrupt protein-protein interactions. Use gentle lysis buffers that preserve CAF20's interactions with eIF4E and ribosomes.
Salt concentration: Higher salt concentrations can reduce non-specific binding but may also disrupt weaker interactions. Test both low and high salt conditions (as shown in studies of CAF20 mutants) .
Tag interference: If using tagged versions of CAF20, the tag might interfere with certain interactions. Consider using different tags (FLAG, TAP) or native antibodies against CAF20.
RNA-dependent interactions: Some CAF20 interactions are RNA-dependent and sensitive to RNase treatment . If studying RNA-dependent interactions, avoid RNase contamination.
Protein modifications: Phosphorylation of CAF20 by TORC1 may affect antibody recognition. Be aware of how growth conditions and cell treatments might alter CAF20 phosphorylation status.
To optimize studies of CAF20 binding to ribosomes:
Use sucrose cushion fractionation: This technique effectively separates cell extracts into ribosome-bound and free fractions, allowing evaluation of CAF20 association with ribosomes .
Include appropriate controls: Use antibodies to ribosomal proteins (such as Rps3 and Rpl35) to track ribosomes and markers like Pgk1 to mark supernatant fractions .
Consider salt concentration: Higher salt concentrations may weaken CAF20-ribosome interactions.
Test CAF20 mutants: Various CAF20 deletion mutants have different effects on ribosome association. Multiple regions along CAF20 contribute to ribosome binding, with deletions in the C-terminal half of CAF20 (Δ5-Δ8) reducing ribosome association by twofold .
Evaluate eIF4E independence: The CAF20 m2 mutant, which cannot bind eIF4E, still associates with ribosomes, confirming that CAF20-ribosome interactions are independent of its ability to bind to eIF4E .
Understanding CAF20's association with ribosomes may provide insights into its role in translation regulation beyond the canonical 4E-BP mechanism of competition with eIF4G for eIF4E binding.